Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MBRX similar filings
- 14 Jun 24 Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial
- 16 May 24 Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress
- 15 May 24 Regulation FD Disclosure
- 14 May 24 Regulation FD Disclosure
- 13 May 24 Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
- 13 May 24 Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
- 9 May 24 Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Filing view
External links
Exhibit 99.1
![slide01.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide01.jpg)
![slide02.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide02.jpg)
![slide03.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide03.jpg)
![slide04.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide04.jpg)
![slide05.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide05.jpg)
![slide06.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide06.jpg)
![slide07.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide07.jpg)
![slide08.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide08.jpg)
![slide09.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide09.jpg)
![slide10.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide10.jpg)
![slide11.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide11.jpg)
![slide12.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide12.jpg)
![slide13.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide13.jpg)
![slide14.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide14.jpg)
![slide15.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide15.jpg)
![slide16.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide16.jpg)
![slide17.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide17.jpg)
![slide18.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide18.jpg)
![slide19.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide19.jpg)
![slide20.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide20.jpg)
![slide21.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide21.jpg)
![slide22.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide22.jpg)
![slide23.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide23.jpg)
![slide24.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide24.jpg)
![slide25.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide25.jpg)
![slide26.jpg](https://capedge.com/proxy/8-K/0001437749-24-016631/slide26.jpg)